Learning Objective #1: Develop an intervention to reduce the intentional non-adherence to antihypertensive medications | |||
Learning Objective #2: Discuss predictors of intentional and unintentional non-adherence to antihypertensive medication regimens |
The data for this analysis was obtained from baseline data of an ongoing HBP intervention trial. A total of 401 KA with HBP was enrolled in the trial, 187 of who were on hypertensive medication were included in this analysis. Theoretically selected variables for this analysis are following: demographic and clinical variables, knowledge, belief, and self-efficacy regarding HBP, satisfaction with care.
Approximately 27.3% of the subjects reported intentional non-adherence while 28.9% reported unintentional non-adherence. After controlling for demographic variables, multivariate analysis revealed that a greater number of adverse effects (Adjusted OR 1.20 : 95% CI, 1.01 to 1.35), a lesser number of co-morbid conditions(Adjusted OR 0.51 : 95% CI, 0.27 to 0.97), and a lower level of HBP knowledge(Adjusted OR 0.89 : 95% CI, 0.79 to 0.99) were significantly associated with intentional non-adherence. Unintentional non-adherence was less strongly associated with all variables.
This results indicate that non-adherence to antihypertensive medication is prevalent among hypertensive KA. The results of this study also highlight the need of an intervention that focuses on increasing patient knowledge about HBP including benefit, side effect or unpleasant symptoms of HBP medication as it will reduce the intentional non-adherence to antihypertensive medications and ultimately helpful in achieving adequate BP control.
See more of Poster Presentations III
See more of The 17th International Nursing Research Congress Focusing on Evidence-Based Practice (19-22 July 2006)